RDY 476 (Primidone 250 mg)
Pill imprint RDY 476 has been identified as Primidone 250 mg.
Primidone is used in the treatment of benign essential tremor; seizures and belongs to the drug class barbiturate anticonvulsants. FDA has not classified the drug for risk during pregnancy. Primidone 250 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
More about primidone
- Other brands: Mysoline
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.